Verici Dx plc (AIM:VRCI)
London
· Delayed Price · Currency is GBP · Price in GBX 1.785
-0.090 (-4.80%)
Apr 25, 2025, 4:17 PM GMT+1
Verici Dx Employees
Verici Dx had 14 employees as of December 31, 2023. The number of employees decreased by 1 or -6.67% compared to the previous year.
Employees
14
Change (1Y)
-1
Growth (1Y)
-6.67%
Revenue / Employee
180.45K GBP
Profits / Employee
-200.27K GBP
Market Cap
4.55M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 14 | -1 | -6.67% |
| Dec 31, 2022 | 15 | 5 | 50.00% |
| Dec 31, 2021 | 10 | 2 | 25.00% |
| Dec 31, 2020 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Oxford Nanopore Technologies | 1,315 |
Verici Dx News
- 15 days ago - AIM Market Roundup: Ethernity Networks, Verici DX, Aferian - The Armchair Trader
- 16 days ago - AIM Market Roundup: Rome Resources, Celadon Pharmaceuticals, Churchill China - The Armchair Trader
- 18 days ago - AIM Market Roundup: Celadon Pharma, Oracle Power, Volex - The Armchair Trader
- 5 months ago - FBB Biomed Signs Agreement with Verici Dx plc to Offer Research-Use-Only “RUO” Tests to Clinicians - Business Wire